Alzheimer’s Disease/Dementia News

SAN DIEGO – Individuals caring for those with dementia “surprisingly” experienced reduced anxiety and depression during the COVID-19 related lockdowns, per a presentation at the Alzheimer’s Association International Conference.

A consortium led by Weill Cornell Medicine has been awarded a $14.7 million NIH grant for its research center, which focuses on emerging and existing technologies that provide support for older adults with cognitive impairments.

Cognivue, a neuroscience company, announced it will launch a national study to differentiate the effectiveness of its cognitive assessment systems.

McLean Hospital in Belmont, Massachusetts, has been named the top hospital in the United States for psychiatric care by the U.S. News & World Report for 2022 to 2023.

Dementia cases in the United States were largely associated with modifiable risk factors, such as hypertension, obesity and physical inactivity — especially among Black and Hispanic people, researchers reported in JAMA Network Open.

The NIH awarded a $45 million grant over 5 years to Burke Neurological Institute to evaluate benfotiamine, a synthetic precursor of thiamine, as a potential therapy for mild Alzheimer’s disease or mild cognitive impairment.

The NIH has awarded researchers at the University of Illinois Urbana-Champaign more than $420,000 to develop ultrasound imaging methods to study neurovascular changes underlying Alzheimer’s disease.

A new study demonstrated that obstructive sleep apnea has an acute effect on biomarkers for Alzheimer’s disease and the ability to measure such biomarkers from blood.

Angiotensin receptor blockers may reduce progression from mild cognitive impairment to dementia in patients undergoing antihypertensive treatment, researchers wrote in Hypertension.

Individuals aged 65 years and older with a history of hypothyroidism were associated with an 81% increased risk for dementia, researchers reported in Neurology.